Last update 21 Nov 2024

Daxdilimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Daxdilimab (USAN), anti-ILT7 antibody
+ [2]
Target
Mechanism
LILRA4 inhibitors(Leukocyte immunoglobulin-like receptor subfamily A member 4 inhibitors), Dendritic cells modulators
Originator Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D11778--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lupus Erythematosus, DiscoidPhase 2
FR
29 Dec 2022
Alopecia AreataPhase 2
US
27 Apr 2022
Alopecia AreataPhase 2
CA
27 Apr 2022
Lupus Erythematosus, CutaneousPhase 2
JP
30 Jan 2022
Lupus Erythematosus, CutaneousPhase 2
JP
30 Jan 2022
Systemic Lupus ErythematosusPhase 2
GR
28 May 2021
Systemic Lupus ErythematosusPhase 2
IN
28 May 2021
Systemic Lupus ErythematosusPhase 2
MX
28 May 2021
Systemic Lupus ErythematosusPhase 2
UA
28 May 2021
Systemic Lupus ErythematosusPhase 2
RU
28 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
155
Placebo+Daxdilimab
(Placebo/Daxdilimab 200 mg Q12W)
uqadexoydu(whyteyshvw) = qweckhvppk phvtmcorgw (uuowxcetrq, prratibxlt - wgmqakfzsx)
-
19 Sep 2024
(Daxdilimab 200 mg Q4W in Parent Study)
uqadexoydu(whyteyshvw) = azptpatexu phvtmcorgw (uuowxcetrq, lmfaxgwfba - htfrzfhgcq)
Phase 2
214
placebo
(Placebo)
aucondqjrz(zukvjzohxi) = gifhmqfzmo xdpkzrfadf (dvouzubfet, srhvfcsruv - cweomvtnvy)
-
23 Jul 2024
(Daxdilimab 200 mg Q4W)
aucondqjrz(zukvjzohxi) = lzbgfmtvez xdpkzrfadf (dvouzubfet, rjehsduulm - axdxgkwdap)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free